Osaka, Japan

Wataru Izui

This inventor holds 5 USPTO granted patents and 5 published patent applications. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wataru Izui. Retrieved from https://idiyas.com/inventor/wataru-izui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Biography of Wataru Izui

Introduction

Wataru Izui is a prominent inventor based in Osaka, Japan, known for his significant contributions to pharmaceutical innovations. With a total of three patents to his name, he has made strides in the development of stable pharmaceutical preparations.

Latest Patents

His latest patents include a preparation containing saxagliptin and a method for producing the same, which focuses on enhancing the stability of saxagliptin formulations. This invention features a plain tablet part with specific additive agents and a film coating part that ensures the effective delivery of saxagliptin. Another notable patent is an additive composition for orally disintegrating tablets, which improves the disintegration properties and hardness of the tablets, utilizing a unique combination of D-mannitol, low-substituted hydroxypropyl cellulose, crospovidone, and crystalline cellulose.

Career Highlights

Wataru Izui is currently employed at Sawai Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing drug formulation technologies, particularly in creating more effective and stable medications.

Collaborations

Throughout his career, Wataru has collaborated with esteemed colleagues such as Kenji Nozawa and Yoichi Higashiyama, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.

Conclusion

Watar

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…